Temat: "immune tolerance" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Immunological Aspects of Infertility-The Role of KIR Receptors and HLA-C Antigen.
Autorzy:: Wasilewska A; Laboratory of Immunogenetics, University Clinical Center, Medical University of Warsaw, 02-091 Warsaw, Poland.
Grabowska M; Laboratory of Immunogenetics, University Clinical Center, Medical University of Warsaw, 02-091 Warsaw, Poland.
Moskalik-Kierat D; Laboratory of Immunogenetics, University Clinical Center, Medical University of Warsaw, 02-091 Warsaw, Poland.
Brzoza M; Laboratory of Immunogenetics, University Clinical Center, Medical University of Warsaw, 02-091 Warsaw, Poland.
Laudański P; Department of Obstetrics, Gynecology and Gynecological Oncology, Medical University of Warsaw, 02-091 Warsaw, Poland.; Women's Health Research Institute, Calisia University, 62-800 Kalisz, Poland.; OVIklinika Infertility Center, 01-377 Warsaw, Poland.
Garley M; Department of Immunology, Medical University of Bialystok, 15-269 Białystok, Poland.; Pokaż więcej
Źródło:: Cells [Cells] 2023 Dec 27; Vol. 13 (1). Date of Electronic Publication: 2023 Dec 27.
Typ publikacji:: Journal Article; Review
MeSH Terms:: HLA-C Antigens*
Infertility*/immunology
Immune Tolerance*
Female ; Humans ; Pregnancy ; Antigen Presentation ; Germ Cells/immunology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Reproductive outcomes after pregnancy-induced displacement of preexisting microchimeric cells.
Autorzy:: Shao TY; Division of Infectious Diseases, Center for Inflammation and Tolerance, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH 45229, USA.
Kinder JM; Division of Infectious Diseases, Center for Inflammation and Tolerance, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH 45229, USA.
Harper G; Division of Infectious Diseases, Center for Inflammation and Tolerance, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH 45229, USA.
Pham G; Division of Infectious Diseases, Center for Inflammation and Tolerance, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH 45229, USA.
Peng Y; Division of Infectious Diseases, Center for Inflammation and Tolerance, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH 45229, USA.
Liu J; Department of Obstetrics and Gynecology, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA.
Gregory EJ; Department of Obstetrics and Gynecology, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA.
Sherman BE; Division of Infectious Diseases, Center for Inflammation and Tolerance, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH 45229, USA.
Wu Y; Division of Infectious Diseases, Center for Inflammation and Tolerance, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH 45229, USA.
Iten AE; Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH 45229, USA.
Hu YC; Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH 45229, USA.
Russi AE; Division of Gastroenterology, Hepatology and Advanced Nutrition, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH 45229, USA.
Erickson JJ; Division of Neonatology, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH 45229, USA.
Miller-Handley H; Division of Infectious Diseases, Center for Inflammation and Tolerance, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH 45229, USA.; Division of Infectious Diseases, Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA.
Way SS; Division of Infectious Diseases, Center for Inflammation and Tolerance, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH 45229, USA.; Pokaż więcej
Źródło:: Science (New York, N.Y.) [Science] 2023 Sep 22; Vol. 381 (6664), pp. 1324-1330. Date of Electronic Publication: 2023 Sep 21.
Typ publikacji:: Journal Article
MeSH Terms:: Pregnancy*/immunology
Chimerism*
Fetus*/cytology
Fetus*/immunology
Immune Tolerance*
Maternal-Fetal Exchange*/immunology
Immunologic Memory*
Animals ; Female ; Mice ; Antigens/immunology ; Cell Plasticity ; Forkhead Transcription Factors/immunology ; Mice, Inbred C57BL ; T-Lymphocytes, Regulatory/immunology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: How mothers tolerate their children.
Autorzy:: Porrett PM; Department of Surgery, University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL, USA.; Pokaż więcej
Źródło:: Science (New York, N.Y.) [Science] 2023 Sep 22; Vol. 381 (6664), pp. 1286. Date of Electronic Publication: 2023 Sep 21.
Typ publikacji:: Journal Article
MeSH Terms:: Immune Tolerance*
Maternal-Fetal Exchange*/immunology
Fetus*/cytology
Fetus*/immunology
Chimerism*
Child ; Female ; Humans ; Pregnancy ; Antigens/immunology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: New Insights in Immunometabolism in Neonatal Monocytes and Macrophages in Health and Disease.
Autorzy:: de Jong R; Department of Pediatrics, RWTH Aachen University, 52074 Aachen, Germany.
Tenbrock K; Department of Pediatrics, RWTH Aachen University, 52074 Aachen, Germany.
Ohl K; Department of Pediatrics, RWTH Aachen University, 52074 Aachen, Germany.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Sep 16; Vol. 24 (18). Date of Electronic Publication: 2023 Sep 16.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Autoimmune Diseases*
Monocytes*
Immune Tolerance*
Adult ; Humans ; Infant, Newborn ; Citric Acid Cycle ; Macrophages

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers.
Autorzy:: Fidelle M; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France.; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Équipe Labellisée - Ligue Nationale contre le Cancer, Villejuif, France.
Rauber C; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France.; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Équipe Labellisée - Ligue Nationale contre le Cancer, Villejuif, France.; Department of Gastroenterology and Infectious Diseases, University Hospital Heidelberg, Heidelberg, Germany.
Alves Costa Silva C; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France.; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Équipe Labellisée - Ligue Nationale contre le Cancer, Villejuif, France.
Tian AL; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France.; Centre de Recherche des Cordeliers, INSERM U1138, Équipe Labellisée - Ligue Nationale contre le Cancer, Université Paris Cité, Sorbonne Université, Paris, France.; Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France.
Lahmar I; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France.; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Équipe Labellisée - Ligue Nationale contre le Cancer, Villejuif, France.
de La Varende AM; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France.; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Équipe Labellisée - Ligue Nationale contre le Cancer, Villejuif, France.
Zhao L; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Centre de Recherche des Cordeliers, INSERM U1138, Équipe Labellisée - Ligue Nationale contre le Cancer, Université Paris Cité, Sorbonne Université, Paris, France.; Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France.
Thelemaque C; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Équipe Labellisée - Ligue Nationale contre le Cancer, Villejuif, France.
Lebhar I; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Équipe Labellisée - Ligue Nationale contre le Cancer, Villejuif, France.
Messaoudene M; Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, Quebec, Canada.
Pizzato E; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Équipe Labellisée - Ligue Nationale contre le Cancer, Villejuif, France.
Birebent R; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France.; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Équipe Labellisée - Ligue Nationale contre le Cancer, Villejuif, France.
Mbogning Fonkou MD; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Équipe Labellisée - Ligue Nationale contre le Cancer, Villejuif, France.
Zoppi S; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France.; Department of Medicine and Surgery, University of Parma, Parma, Italy.
Reni A; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France.; Section of Oncology, Department of Medicine, University of Verona School of Medicine and Verona University Hospital Trust, Verona, Italy.
Dalban C; Clinical Research Department, Centre Léon Bérard, Lyon, France.
Leduc M; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Centre de Recherche des Cordeliers, INSERM U1138, Équipe Labellisée - Ligue Nationale contre le Cancer, Université Paris Cité, Sorbonne Université, Paris, France.; Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France.
Ferrere G; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Équipe Labellisée - Ligue Nationale contre le Cancer, Villejuif, France.; EverImmune, Gustave Roussy Cancer Campus, Villejuif Cedex, France.
Durand S; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Centre de Recherche des Cordeliers, INSERM U1138, Équipe Labellisée - Ligue Nationale contre le Cancer, Université Paris Cité, Sorbonne Université, Paris, France.; Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France.
Ly P; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Équipe Labellisée - Ligue Nationale contre le Cancer, Villejuif, France.; Center of Clinical Investigations in Biotherapies of Cancer (BIOTHERIS), Villejuif, France.
Silvin A; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Équipe Labellisée - Ligue Nationale contre le Cancer, Villejuif, France.
Mulder K; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France.; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Équipe Labellisée - Ligue Nationale contre le Cancer, Villejuif, France.
Dutertre CA; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Équipe Labellisée - Ligue Nationale contre le Cancer, Villejuif, France.
Ginhoux F; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Équipe Labellisée - Ligue Nationale contre le Cancer, Villejuif, France.
Yonekura S; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France.; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Équipe Labellisée - Ligue Nationale contre le Cancer, Villejuif, France.
Roberti MP; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Équipe Labellisée - Ligue Nationale contre le Cancer, Villejuif, France.; Clinical Cooperation Unit Applied Tumor Immunity, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Medical Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital (UKHD), Heidelberg, Germany.
Tidjani-Alou M; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Équipe Labellisée - Ligue Nationale contre le Cancer, Villejuif, France.
Terrisse S; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France.; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Équipe Labellisée - Ligue Nationale contre le Cancer, Villejuif, France.
Chen J; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Équipe Labellisée - Ligue Nationale contre le Cancer, Villejuif, France.
Kepp O; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Centre de Recherche des Cordeliers, INSERM U1138, Équipe Labellisée - Ligue Nationale contre le Cancer, Université Paris Cité, Sorbonne Université, Paris, France.; Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France.
Schippers A; Department of Pediatrics, University Hospital RWTH Aachen, Aachen, Germany.
Wagner N; Department of Pediatrics, University Hospital RWTH Aachen, Aachen, Germany.
Suárez-Gosálvez J; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, Klinikum der Universität München, LMU Munich, Germany.
Kobold S; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, Klinikum der Universität München, LMU Munich, Germany.; German Cancer Consortium (DKTK), partner site Munich, Munich, Germany.
Fahrner JE; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France.; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Équipe Labellisée - Ligue Nationale contre le Cancer, Villejuif, France.
Richard C; Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, Quebec, Canada.
Bosq J; JBO Consultant, Paris, France.
Lordello L; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Équipe Labellisée - Ligue Nationale contre le Cancer, Villejuif, France.
Vitali G; MetaGenoPolis, INRAe, Université Paris-Saclay, Jouy en Josas, France.
Galleron N; MetaGenoPolis, INRAe, Université Paris-Saclay, Jouy en Josas, France.
Quinquis B; MetaGenoPolis, INRAe, Université Paris-Saclay, Jouy en Josas, France.
Le Chatelier E; MetaGenoPolis, INRAe, Université Paris-Saclay, Jouy en Josas, France.
Blanchard L; Institut de Pharmacologie et de Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France.
Girard JP; Institut de Pharmacologie et de Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France.
Jarry A; Nantes Université, Université d'Angers, INSERM, CNRS, Immunology and New Concepts in ImmunoTherapy, INCIT, UMR 1302/EMR6001, Nantes, France.
Gervois N; Nantes Université, Université d'Angers, INSERM, CNRS, Immunology and New Concepts in ImmunoTherapy, INCIT, UMR 1302/EMR6001, Nantes, France.
Godefroy E; Nantes Université, Université d'Angers, INSERM, CNRS, Immunology and New Concepts in ImmunoTherapy, INCIT, UMR 1302/EMR6001, Nantes, France.
Labarrière N; Nantes Université, Université d'Angers, INSERM, CNRS, Immunology and New Concepts in ImmunoTherapy, INCIT, UMR 1302/EMR6001, Nantes, France.; LabEx IGO, Université de Nantes, Nantes, France.
Koschny R; Department of Gastroenterology and Infectious Diseases, University Hospital Heidelberg, Heidelberg, Germany.
Daillère R; EverImmune, Gustave Roussy Cancer Campus, Villejuif Cedex, France.
Besse B; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France.
Truntzer C; Université de Bourgogne Franche-Comté, Plateforme de Transfert de Biologie du Cancer, Centre Georges-François Leclerc, Equipe Labellisée Ligue Nationale Contre le Cancer, Centre de Recherche INSERM LNC-UMR1231, Institut Médical de Génétique et d'Immunologie, Dijon, France.
Ghiringhelli F; Université de Bourgogne Franche-Comté, Plateforme de Transfert de Biologie du Cancer, Centre Georges-François Leclerc, Equipe Labellisée Ligue Nationale Contre le Cancer, Centre de Recherche INSERM LNC-UMR1231, Institut Médical de Génétique et d'Immunologie, Dijon, France.
Coatnoan N; AP-HP, Hôpital Pitié-Salpêtrière, Clinical Investigation Center for Biotherapies (CIC-BTi) and Immunology-Inflammation-Infectiology and Dermatology Department (3iD), Paris, France.; Sorbonne Université, INSERM, UMRS959 Immunology-Immunopathology-Immunotherapy Laboratory, Paris, France.
Mhanna V; AP-HP, Hôpital Pitié-Salpêtrière, Clinical Investigation Center for Biotherapies (CIC-BTi) and Immunology-Inflammation-Infectiology and Dermatology Department (3iD), Paris, France.; Sorbonne Université, INSERM, UMRS959 Immunology-Immunopathology-Immunotherapy Laboratory, Paris, France.
Klatzmann D; AP-HP, Hôpital Pitié-Salpêtrière, Clinical Investigation Center for Biotherapies (CIC-BTi) and Immunology-Inflammation-Infectiology and Dermatology Department (3iD), Paris, France.; Sorbonne Université, INSERM, UMRS959 Immunology-Immunopathology-Immunotherapy Laboratory, Paris, France.
Drubay D; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Office of Biostatistics and Epidemiology, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France.; Inserm, Université Paris-Saclay, CESP U1018, Oncostat, labeled Ligue Contre le Cancer, Villejuif, France.
Albiges L; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France.
Thomas AM; Department of Computational, Cellular and Integrative Biology, University of Trento, Trento, Italy.
Segata N; Department of Computational, Cellular and Integrative Biology, University of Trento, Trento, Italy.; Istituto Europeo di Oncologia (IEO), National Cancer Institute (IRCCS), Milan, Italy.
Danlos FX; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France.; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Équipe Labellisée - Ligue Nationale contre le Cancer, Villejuif, France.; Center of Clinical Investigations in Biotherapies of Cancer (BIOTHERIS), Villejuif, France.; Drug Development Department, Gustave Roussy Cancer Campus, Villejuif Cedex, France.
Marabelle A; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France.; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Équipe Labellisée - Ligue Nationale contre le Cancer, Villejuif, France.; Center of Clinical Investigations in Biotherapies of Cancer (BIOTHERIS), Villejuif, France.; Drug Development Department, Gustave Roussy Cancer Campus, Villejuif Cedex, France.
Routy B; Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, Quebec, Canada.; Hematology-Oncology Division, Department of Medicine, Centre Hospitalier de l'Université de Montréal (CHUM), Montréal, Quebec, Canada.
Derosa L; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France.; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Équipe Labellisée - Ligue Nationale contre le Cancer, Villejuif, France.; Center of Clinical Investigations in Biotherapies of Cancer (BIOTHERIS), Villejuif, France.
Kroemer G; Centre de Recherche des Cordeliers, INSERM U1138, Équipe Labellisée - Ligue Nationale contre le Cancer, Université Paris Cité, Sorbonne Université, Paris, France.; Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France.; Institut du Cancer Paris CARPEM, Department of Biology, Hôpital Européen Georges Pompidou, Assistance Publique - Hôpitaux de Paris (AP-HP), Paris, France.
Zitvogel L; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France.; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Équipe Labellisée - Ligue Nationale contre le Cancer, Villejuif, France.; Center of Clinical Investigations in Biotherapies of Cancer (BIOTHERIS), Villejuif, France.; Pokaż więcej
Źródło:: Science (New York, N.Y.) [Science] 2023 Jun 09; Vol. 380 (6649), pp. eabo2296. Date of Electronic Publication: 2023 Jun 09.
Typ publikacji:: Journal Article
MeSH Terms:: Anti-Bacterial Agents*/adverse effects
Cell Adhesion Molecules*/metabolism
Drug Resistance, Neoplasm*
Gastrointestinal Microbiome*/immunology
Immune Checkpoint Inhibitors*/therapeutic use
Immune Tolerance*/drug effects
Immunologic Surveillance*
Integrins*/metabolism
Mucoproteins*/metabolism
Neoplasms*/immunology
Neoplasms*/therapy
Animals ; Humans ; Mice ; Bacteria/immunology ; Cell Movement ; Fecal Microbiota Transplantation ; Interleukin-17/metabolism ; Th17 Cells/immunology ; Gastrointestinal Tract/immunology ; Gastrointestinal Tract/microbiology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Analysis of thymic generation of shared T-cell receptor α repertoire associated with recognition of tumor antigens shows no preference for neoantigens over wild-type antigens.
Autorzy:: Mattila J; Research Programs Unit, Translational Immunology, Haartmaninkatu 3 (PL 21) 00014, and Medicum, University of Helsinki, Helsinki, Finland.
Sormunen S; Department of Computer Science, Aalto University, Espoo, Finland.
Heikkilä N; Research Programs Unit, Translational Immunology, Haartmaninkatu 3 (PL 21) 00014, and Medicum, University of Helsinki, Helsinki, Finland.; Faculty of Medicine, Center for Vaccinology, Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland.
Mattila IP; Department of Pediatric Cardiac and Transplantation Surgery, Hospital for Children and Adolescents, Helsinki University Central Hospital, Helsinki, Finland.
Saramäki J; Department of Computer Science, Aalto University, Espoo, Finland.
Arstila TP; Research Programs Unit, Translational Immunology, Haartmaninkatu 3 (PL 21) 00014, and Medicum, University of Helsinki, Helsinki, Finland.; Pokaż więcej
Źródło:: Cancer medicine [Cancer Med] 2023 Jun; Vol. 12 (12), pp. 13486-13496. Date of Electronic Publication: 2023 Apr 28.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Thymus Gland*/immunology
Antigens, Neoplasm*/genetics
Antigens, Neoplasm*/immunology
Neoplasms*/genetics
Neoplasms*/immunology
Neoplasms*/therapy
Immune Tolerance*/genetics
Receptors, Antigen, T-Cell, alpha-beta*/genetics
Receptors, Antigen, T-Cell, alpha-beta*/immunology
Humans ; Mutation

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Resetting tolerance in autoimmune disease.
Autorzy:: Muraro PA; Department of Brain Sciences, Imperial College London, London, UK.; Neurology, Imperial College London NHS Trust, London, UK.; Pokaż więcej
Źródło:: Science (New York, N.Y.) [Science] 2023 May 05; Vol. 380 (6644), pp. 470-471. Date of Electronic Publication: 2023 May 04.
Typ publikacji:: Journal Article
MeSH Terms:: Autoimmune Diseases*/therapy
Hematopoietic Stem Cell Transplantation*
Immune Tolerance*
Humans ; Transplantation, Autologous

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: LILRB4 Checkpoint for Immunotherapy: Structure, Mechanism and Disease Targets.
Autorzy:: Xiang Z; Department of Immunology, Xiangya School of Medicine, Central South University, Changsha 410078, China.
Yin X; Department of Immunology, Xiangya School of Medicine, Central South University, Changsha 410078, China.
Wei L; Department of Immunology, Xiangya School of Medicine, Central South University, Changsha 410078, China.
Peng M; Department of Immunology, Xiangya School of Medicine, Central South University, Changsha 410078, China.
Zhu Q; Department of Immunology, Xiangya School of Medicine, Central South University, Changsha 410078, China.
Lu X; Department of Immunology, Xiangya School of Medicine, Central South University, Changsha 410078, China.
Guo J; Department of Immunology, Xiangya School of Medicine, Central South University, Changsha 410078, China.
Zhang J; Department of Immunology, Xiangya School of Medicine, Central South University, Changsha 410078, China.
Li X; Department of Immunology, Xiangya School of Medicine, Central South University, Changsha 410078, China.
Zou Y; Department of Immunology, Xiangya School of Medicine, Central South University, Changsha 410078, China.; Pokaż więcej
Źródło:: Biomolecules [Biomolecules] 2024 Feb 04; Vol. 14 (2). Date of Electronic Publication: 2024 Feb 04.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Leukocytes*
Autoimmune Diseases*/therapy
Humans ; Immune Tolerance ; Ligands ; Immunotherapy ; Membrane Glycoproteins ; Receptors, Immunologic

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Grafted Sertoli Cells Exert Immunomodulatory Non-Immunosuppressive Effects in Preclinical Models of Infection and Cancer.
Autorzy:: Chiappalupi S; Department of Medicine and Surgery, University of Perugia, 06132 Perugia, Italy.; Interuniversity Institute of Myology (IIM), 06132 Perugia, Italy.; Consorzio Interuniversitario Biotecnologie (CIB), 34127 Trieste, Italy.
Salvadori L; Interuniversity Institute of Myology (IIM), 06132 Perugia, Italy.; Department of Translational Medicine, University of Piemonte Orientale, 28100 Novara, Italy.
Borghi M; Department of Medicine and Surgery, University of Perugia, 06132 Perugia, Italy.
Mancuso F; Department of Medicine and Surgery, University of Perugia, 06132 Perugia, Italy.
Pariano M; Department of Medicine and Surgery, University of Perugia, 06132 Perugia, Italy.
Riuzzi F; Department of Medicine and Surgery, University of Perugia, 06132 Perugia, Italy.; Interuniversity Institute of Myology (IIM), 06132 Perugia, Italy.; Consorzio Interuniversitario Biotecnologie (CIB), 34127 Trieste, Italy.
Luca G; Department of Medicine and Surgery, University of Perugia, 06132 Perugia, Italy.; Centro Biotecnologico Internazionale di Ricerca Traslazionale ad indirizzo Endocrino, Metabolico ed Embrio-Riproduttivo (CIRTEMER), 06132 Perugia, Italy.; Centro Universitario di Ricerca sulla Genomica Funzionale (CURGeF), 06132 Perugia, Italy.
Romani L; Department of Medicine and Surgery, University of Perugia, 06132 Perugia, Italy.
Arato I; Department of Medicine and Surgery, University of Perugia, 06132 Perugia, Italy.
Sorci G; Department of Medicine and Surgery, University of Perugia, 06132 Perugia, Italy.; Interuniversity Institute of Myology (IIM), 06132 Perugia, Italy.; Consorzio Interuniversitario Biotecnologie (CIB), 34127 Trieste, Italy.; Centro Biotecnologico Internazionale di Ricerca Traslazionale ad indirizzo Endocrino, Metabolico ed Embrio-Riproduttivo (CIRTEMER), 06132 Perugia, Italy.; Centro Universitario di Ricerca sulla Genomica Funzionale (CURGeF), 06132 Perugia, Italy.; Pokaż więcej
Źródło:: Cells [Cells] 2024 Mar 19; Vol. 13 (6). Date of Electronic Publication: 2024 Mar 19.
Typ publikacji:: Journal Article
MeSH Terms:: Sertoli Cells*/metabolism
Carcinoma, Lewis Lung*/metabolism
Male ; Humans ; Swine ; Animals ; Mice ; Seminiferous Tubules/metabolism ; Immunosuppressive Agents/therapeutic use ; Immune Tolerance

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Exosome-transmitted podoplanin promotes tumor-associated macrophage-mediated immune tolerance in glioblastoma.
Autorzy:: Wu M; Department of Oncology, Sichuan Academy of Medical Sciences, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, China.; Yu-Yue Pathology Scientific Research Center, Chongqing, China.; Jinfeng Laboratory, Chongqing, China.
Shi Y; Department of Oncology, Sichuan Academy of Medical Sciences, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, China.
Liu Y; Department of Neurosurgery, 920th Hospital of Joint Logistics Support Force, Kunming, China.
Huang H; Department of Oncology, The First Affiliated Hospital, Nanchang University, Nanchang, China.
Che J; Department of Oncology, Sichuan Academy of Medical Sciences, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, China.
Shi J; Department of Neurosurgery, 920th Hospital of Joint Logistics Support Force, Kunming, China.
Xu C; Department of Oncology, Sichuan Academy of Medical Sciences, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, China.; Yu-Yue Pathology Scientific Research Center, Chongqing, China.; Jinfeng Laboratory, Chongqing, China.; Pokaż więcej
Źródło:: CNS neuroscience & therapeutics [CNS Neurosci Ther] 2024 Mar; Vol. 30 (3), pp. e14643.
Typ publikacji:: Journal Article
MeSH Terms:: Exosomes*/metabolism
Glioblastoma*/pathology
Glioma*/metabolism
Animals ; Humans ; Mice ; Immune Tolerance ; Transcription Factors ; Tumor-Associated Macrophages/metabolism ; Tumor-Associated Macrophages/pathology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Evaluating the Effects of Chronic Oral Exposure to the Food Additive Silicon Dioxide on Oral Tolerance Induction and Food Sensitivities in Mice.
Autorzy:: Lamas B; Toxalim (Research Centre in Food Toxicology), Team Endocrinology and Toxicology of Intestinal Barrier, INRAE/ENVT/Paul Sabatier University, Toulouse, France.
Martins Breyner N; Toxalim (Research Centre in Food Toxicology), Team Endocrinology and Toxicology of Intestinal Barrier, INRAE/ENVT/Paul Sabatier University, Toulouse, France.
Malaisé Y; Toxalim (Research Centre in Food Toxicology), Team Endocrinology and Toxicology of Intestinal Barrier, INRAE/ENVT/Paul Sabatier University, Toulouse, France.
Wulczynski M; Farncombe Family Digestive Health Research Institute, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Galipeau HJ; Farncombe Family Digestive Health Research Institute, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Gaultier E; Toxalim (Research Centre in Food Toxicology), Team Endocrinology and Toxicology of Intestinal Barrier, INRAE/ENVT/Paul Sabatier University, Toulouse, France.
Cartier C; Toxalim (Research Centre in Food Toxicology), Team Endocrinology and Toxicology of Intestinal Barrier, INRAE/ENVT/Paul Sabatier University, Toulouse, France.
Verdu EF; Farncombe Family Digestive Health Research Institute, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Houdeau E; Toxalim (Research Centre in Food Toxicology), Team Endocrinology and Toxicology of Intestinal Barrier, INRAE/ENVT/Paul Sabatier University, Toulouse, France.; Pokaż więcej
Źródło:: Environmental health perspectives [Environ Health Perspect] 2024 Feb; Vol. 132 (2), pp. 27007. Date of Electronic Publication: 2024 Feb 21.
Typ publikacji:: Journal Article
MeSH Terms:: Interleukin-10*/pharmacology
Silicon Dioxide*/toxicity
Humans ; Animals ; Mice ; Food Additives/pharmacology ; Mice, Inbred C57BL ; Immune Tolerance/genetics ; Glutens/pharmacology ; Ovalbumin/pharmacology ; Administration, Oral ; Mice, Inbred BALB C

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Treg specialization and functions beyond immune suppression.
Autorzy:: Astarita JL; TRex Biosciences, South San Francisco, CA, USA.
Dominguez CX; TRex Biosciences, South San Francisco, CA, USA.
Tan C; TRex Biosciences, South San Francisco, CA, USA.
Guillen J; TRex Biosciences, South San Francisco, CA, USA.
Pauli ML; TRex Biosciences, South San Francisco, CA, USA.
Labastida R; TRex Biosciences, South San Francisco, CA, USA.
Valle J; TRex Biosciences, South San Francisco, CA, USA.
Kleinschek M; TRex Biosciences, South San Francisco, CA, USA.
Lyons J; TRex Biosciences, South San Francisco, CA, USA.
Zarrin AA; TRex Biosciences, South San Francisco, CA, USA.; Pokaż więcej
Źródło:: Clinical and experimental immunology [Clin Exp Immunol] 2023 Mar 16; Vol. 211 (2), pp. 176-183.
Typ publikacji:: Review; Journal Article
MeSH Terms:: T-Lymphocytes, Regulatory*
Immune Tolerance*
Humans ; Animals ; Mice ; Autoimmunity

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: The Tolerogenic Influence of Dexamethasone on Dendritic Cells Is Accompanied by the Induction of Efferocytosis, Promoted by MERTK.
Autorzy:: Li V; The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, VIC 3010, Australia.
Binder MD; The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, VIC 3010, Australia.; Department of Anatomy and Physiology, University of Melbourne, Parkville, VIC 3010, Australia.
Kilpatrick TJ; The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, VIC 3010, Australia.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Nov 02; Vol. 24 (21). Date of Electronic Publication: 2023 Nov 02.
Typ publikacji:: Journal Article
MeSH Terms:: Dendritic Cells*
T-Lymphocytes*
c-Mer Tyrosine Kinase/genetics ; c-Mer Tyrosine Kinase/metabolism ; Immunosuppressive Agents/pharmacology ; Immune Tolerance ; Dexamethasone/pharmacology ; Dexamethasone/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: High-dimensional quantum key distribution implemented with biphotons.
Autorzy:: Sekga C; Department of Physics and Astronomy, Botswana International University of Science and Technology, P/Bag 16, Palapye, Botswana.
Mafu M; Department of Physics, Case Western Reserve University, Cleveland, OH, 44106, USA. .
Senekane M; Institute for Intelligent Systems, University of Johannesburg, Johannesburg, 2006, South Africa.; National Institute for Theoretical and Computational Sciences, Gauteng, 2006, South Africa.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2023 Jan 21; Vol. 13 (1), pp. 1229. Date of Electronic Publication: 2023 Jan 21.
Typ publikacji:: Journal Article
MeSH Terms:: Immune Tolerance*
Optical Devices*
Drug Tolerance ; Technology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Inborn errors of immunity associated with defects of self-tolerance checkpoints: The CD28 family.
Autorzy:: Rush-Kittle J; Center for Chronic Immunodeficiency, University Medical Center Freiburg, Freiburg, Germany.
Gámez-Díaz L; Center for Chronic Immunodeficiency, University Medical Center Freiburg, Freiburg, Germany.
Grimbacher B; Center for Chronic Immunodeficiency, University Medical Center Freiburg, Freiburg, Germany.; Pokaż więcej
Źródło:: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology [Pediatr Allergy Immunol] 2022 Dec; Vol. 33 (12), pp. e13886.
Typ publikacji:: Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:: CD28 Antigens*/genetics
CD28 Antigens*/metabolism
Immune Tolerance*
Humans ; Autoimmunity

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: The effect of B-type allatostatin neuropeptides on crosstalk between the insect immune response and cold tolerance.
Autorzy:: Lubawy J; Department of Animal Physiology and Developmental Biology, Institute of Experimental Biology, Faculty of Biology, Adam Mickiewicz University, Poznan, Poland. .
Hornik J; Department of Animal Physiology and Developmental Biology, Institute of Experimental Biology, Faculty of Biology, Adam Mickiewicz University, Poznan, Poland.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2022 Nov 30; Vol. 12 (1), pp. 20697. Date of Electronic Publication: 2022 Nov 30.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Immune Tolerance*
Neuropeptides*
Animals ; Insecta ; Immunity

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Tumors can teem with microbes. But what are they doing there?
Autorzy:: Sinha G; Gunjan Sinha is a science journalist in Berlin.; Pokaż więcej
Źródło:: Science (New York, N.Y.) [Science] 2022 Nov 18; Vol. 378 (6621), pp. 693-694. Date of Electronic Publication: 2022 Nov 17.
Typ publikacji:: Wiadomości
MeSH Terms:: Microbiota*/immunology
Mouth Neoplasms*/immunology
Mouth Neoplasms*/microbiology
Mouth Neoplasms*/pathology
Colorectal Neoplasms*/immunology
Colorectal Neoplasms*/microbiology
Colorectal Neoplasms*/pathology
Immune Tolerance*
Epithelial Cells*/microbiology
Epithelial Cells*/pathology
Humans ; Immunity ; Neoplasm Metastasis ; Animals ; Mice

Periodyk

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Aberrant hyperexpression of the RNA binding protein FMRP in tumors mediates immune evasion.
Autorzy:: Zeng Q; Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Swiss Federal Institute of Technology Lausanne (EPFL), 1015 Lausanne, Switzerland.; Opna Bio SA, Biopole, 1066 Epalinges, Lausanne, Switzerland.
Saghafinia S; Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Swiss Federal Institute of Technology Lausanne (EPFL), 1015 Lausanne, Switzerland.; Opna Bio SA, Biopole, 1066 Epalinges, Lausanne, Switzerland.
Chryplewicz A; Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Swiss Federal Institute of Technology Lausanne (EPFL), 1015 Lausanne, Switzerland.; Agora Cancer Research Center, 1011 Lausanne, Switzerland.
Fournier N; Swiss Institute of Bioinformatics (SIB), 1015 Lausanne, Switzerland.
Christe L; Institute of Pathology, University of Bern, 3008 Bern, Switzerland.
Xie YQ; Institute of Bioengineering, School of Engineering, Swiss Federal Institute of Technology Lausanne (EPFL), 1015 Lausanne, Switzerland.
Guillot J; Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Swiss Federal Institute of Technology Lausanne (EPFL), 1015 Lausanne, Switzerland.; Agora Cancer Research Center, 1011 Lausanne, Switzerland.
Yucel S; Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Swiss Federal Institute of Technology Lausanne (EPFL), 1015 Lausanne, Switzerland.; Agora Cancer Research Center, 1011 Lausanne, Switzerland.
Li P; Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Swiss Federal Institute of Technology Lausanne (EPFL), 1015 Lausanne, Switzerland.; Agora Cancer Research Center, 1011 Lausanne, Switzerland.; Department of Computational Biology, University of Lausanne, 1015 Lausanne, Switzerland.
Galván JA; Institute of Pathology, University of Bern, 3008 Bern, Switzerland.
Karamitopoulou E; Institute of Pathology, University of Bern, 3008 Bern, Switzerland.
Zlobec I; Institute of Pathology, University of Bern, 3008 Bern, Switzerland.
Ataca D; Opna Bio SA, Biopole, 1066 Epalinges, Lausanne, Switzerland.
Gallean F; Opna Bio SA, Biopole, 1066 Epalinges, Lausanne, Switzerland.
Zhang P; Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 100045, China.
Rodriguez-Calero JA; Department for BioMedical Research, University of Bern, 3008 Bern, Switzerland.
Rubin M; Department for BioMedical Research, University of Bern, 3008 Bern, Switzerland.
Tichet M; Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Swiss Federal Institute of Technology Lausanne (EPFL), 1015 Lausanne, Switzerland.; Agora Cancer Research Center, 1011 Lausanne, Switzerland.; Lausanne Branch, Ludwig Institute for Cancer Research, 1011 Lausanne, Switzerland.
Homicsko K; Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Swiss Federal Institute of Technology Lausanne (EPFL), 1015 Lausanne, Switzerland.; Agora Cancer Research Center, 1011 Lausanne, Switzerland.; Lausanne Branch, Ludwig Institute for Cancer Research, 1011 Lausanne, Switzerland.; Department of Oncology, University Hospital of Lausanne (CHUV), 1011 Lausanne, Switzerland.; Swiss Cancer Center Leman (SCCL), 1011 Lausanne, Switzerland.
Hanahan D; Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Swiss Federal Institute of Technology Lausanne (EPFL), 1015 Lausanne, Switzerland.; Agora Cancer Research Center, 1011 Lausanne, Switzerland.; Lausanne Branch, Ludwig Institute for Cancer Research, 1011 Lausanne, Switzerland.; Swiss Cancer Center Leman (SCCL), 1011 Lausanne, Switzerland.; Pokaż więcej
Źródło:: Science (New York, N.Y.) [Science] 2022 Nov 18; Vol. 378 (6621), pp. eabl7207. Date of Electronic Publication: 2022 Nov 18.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Fragile X Mental Retardation Protein*/genetics
Fragile X Mental Retardation Protein*/metabolism
Immune Evasion*
Neoplasms*/immunology
Immune Tolerance*
Animals ; Humans ; Mice ; Chemokine CCL7/metabolism ; Interleukin-33 ; Protein S/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Inhibitor of PD-1/PD-L1: a new approach may be beneficial for the treatment of idiopathic pulmonary fibrosis.
Autorzy:: Tan J; Department of Respiratory Medicine, The Second Hospital of Jilin University, Changchun, China.
Xue Q; Hospital of Jilin University, Changchun, China.
Hu X; Department of Respiratory Medicine, The Second Hospital of Jilin University, Changchun, China.
Yang J; Department of Respiratory Medicine, The Second Hospital of Jilin University, Changchun, China. .; Pokaż więcej
Źródło:: Journal of translational medicine [J Transl Med] 2024 Jan 23; Vol. 22 (1), pp. 95. Date of Electronic Publication: 2024 Jan 23.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Programmed Cell Death 1 Receptor*
Idiopathic Pulmonary Fibrosis*
Humans ; B7-H1 Antigen ; Contraindications ; Immune Tolerance

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Efficacy and safety of adamgammadex for reversing rocuronium-induced deep neuromuscular blockade: A multicenter, randomized, phase IIb study.
Autorzy:: Zhao Y; Department of Anesthesiology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Chen S; Department of Anesthesiology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Xie W; Department of Anesthesiology, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, China.
Zhang X; Department of Anesthesiology, Tongji Hospital of Tongji University, Shanghai, China.
Chen G; Department of Anesthesiology, The 900 Hospital of the Chinese People's Liberation Army Joint Logistic Support Force, Fuzhou, China.
Ji F; Department of Anesthesiology, The First Affiliated Hospital of Soochow University, Suzhou, China.
Wang D; Department of Anesthesiology, Peking University First Hosptial, Beijing, China.
Qi Y; Hangzhou Adamerck Pharmlabs Inc, Hangzhou, China.
Jie Q; Hangzhou Adamerck Pharmlabs Inc, Hangzhou, China.
Su D; Department of Anesthesiology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Yu W; Department of Anesthesiology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Pokaż więcej
Źródło:: Clinical and translational science [Clin Transl Sci] 2024 Jan; Vol. 17 (1), pp. e13691.
Typ publikacji:: Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Neuromuscular Blockade*/adverse effects
Humans ; Rocuronium/adverse effects ; Sugammadex/adverse effects ; Drug Tolerance ; Immune Tolerance

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""immune tolerance"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język

Rok publikacji